CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Naturalendo Tech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Naturalendo Tech Co Ltd
201, E Dong, Pangyo Inno Valley Bldg.
255, Pangyo-Ro, Bundang-Gu
Phone: +82 7046013139p:+82 7046013139 SEONGNAM, 13486  South Korea Ticker: 168330168330
Business Summary
Naturalendo Tech Co.,Ltd. is a Korea-based company principally engaged in the research and development (R&D) and manufacture of hormone biotechnology products. The Company mainly provides novel phytoestrogen, which is applied in the treatment of climacteric. It also provides other hormonal formula, such as hormone disruptor inhibitor, secretagogue and inhibitor used as diet formula and growth hormone. In addition, the Company provides materials used for diet, and involves in the R&D of drug delivery systems, immune enhancer, atopy and acne, plantation factory, and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2844 Perfumes, cosmetics, and other toilet preparations
5122 Drugs, drug proprietaries, and druggists' sundries
2099 Food preparations, not elsewhere classified
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Yong WukLee 50 6/10/2019 6/10/2019
Internal Auditor Byeong JunPark 39
Director Han SuHa 43
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 62 (As of 12/31/2015)
Outstanding Shares: 31,573,341 (As of 12/31/2023)
Shareholders: 14,922
Stock Exchange: KDQ
Fax Number: +82 7046013100


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024